CONTACTAbout UsCAREER OPPORTUNITIESADVERTISE WITH USPRIVACY POLICYPRIVACY PREFERENCESTERMS OF USELEGAL NOTICE
© 2025 Equal Entertainment LLC.
All Rights reserved
All Rights reserved
By continuing to use our site, you agree to our Private Policy and Terms of Use.
The number of HIV patients with Kaposi's sarcoma, a once-rare cancer that became a marker for AIDS in the early days of the epidemic, has declined sharply due to the use of antiretroviral drugs, according to a European study released Monday. The annual incidence of the cancer fell 39% between 1994 and 2003, according to a study of nearly 10,000 HIV-positive people by the Royal Free and University College in London and several other European hospitals and health centers. Kaposi's sarcoma first appears as a brownish skin lesion, although it can also develop in the lungs, liver, and other internal organs. Until AIDS surfaced in 1981, the cancer was seen primarily in elderly Mediterranean men. It became one of the most common ailments plaguing AIDS patients in the 1980s. But the introduction a decade later of highly active antiretroviral therapy gave doctors a powerful new weapon against the opportunistic diseases that killed many AIDS victims. Anecdotal data and small studies had indicated that KS cases were declining as the new drugs suppressed levels of HIV in patients' blood and allowed their immune systems to recover. The large European study was, however, the first conclusive indication of a link between the therapy and declining cases of KS. The findings were published in the May 10 online edition of the American Cancer Society journal Cancer. In their study the Europeans noted that those with a higher current T-cell count or who had been on HAART therapy for a longer period of time had a decreased incidence of the cancer. "This indicates that the current CD4 count remains one of the most important prognostic factors for Kaposi's sarcoma, and patients who start HAART should experience a reduction in the risk of Kaposi's sarcoma if the CD4 count starts to rise," the researchers said. (Reuters)
From our Sponsors
Most Popular
31 Period Films of Lesbians and Bi Women in Love That Will Take You Back
December 09 2024 1:00 PM
18 of the most batsh*t things N.C. Republican governor candidate Mark Robinson has said
October 30 2024 11:06 AM
True
These 15 major companies caved to the far right and stopped DEI programs
January 24 2025 1:11 PM
True
Latest Stories
Federal appeals court upholds block on Trump's trans military ban
April 19 2025 11:17 AM
From Roe to woes, the days SCOTUS hit 'undo' on half a century of progress
April 19 2025 7:00 AM
Federal judge blocks Trump admin's gender-restrictive passport policy
April 18 2025 8:13 PM
Transgender teen can't legally change name until age 21, Mississippi Supreme Court rules
April 18 2025 4:51 PM
Military families sue Trump administration to keep their school system diverse
April 18 2025 2:40 PM
After backlash, Planned Parenthood Arizona resumes gender-affirming care
April 18 2025 2:28 PM
What does WorldPride's travel warning mean for transgender & nonbinary people?
April 18 2025 10:14 AM
Wilton Women’s Week 2025 ushers in a new era of LGBTQ+ empowerment in South Florida
April 18 2025 9:49 AM
Activists stack coffins in front of State Department to protest PEPFAR cuts (in photos)
April 17 2025 3:22 PM
JD Vance wants the UK to repeal its LGBTQ+ hate speech laws to secure a trade deal
April 17 2025 12:37 PM
Chicago Teachers Union ratifies groundbreaking contract cementing LGBTQ+ protections
April 17 2025 7:00 AM
Mahmoud v. Taylor: Everything to know about the Supreme Court case to ban LGBTQ+ books
April 17 2025 6:30 AM